Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Cunningham

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Virological Methods|June 4, 2009
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesSally Land, Philip Cunningham, Jialun Zhou, et al.
The Journal of Molecular Diagnostics : JMD|July 1, 2018
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot SamplesFrançois M J Lamoury, Behzad Hajarizadeh, Angelica Soker, et al.
Open Forum Infectious Diseases|November 29, 2023
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot StudyAnna Conway, Annabelle Stevens, Carolyn Murray, et al.
Sexual Health|April 5, 2019
Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before-after studyPhillip Keen, Muhammad Jamil, Denton Callander, et al.
Journal of the International AIDS Society|July 22, 2024
Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP useJonathan M King, Francesca Di Giallonardo, Ansari Shaik, et al.
Diagnostic Microbiology and Infectious Disease|January 16, 2025
Establishing quality assurance for COVID-19 antigen tests in the Indo Pacific Region: A multi-site implementation studyJacqueline Prestedge, Marilyn Ninan, Chan Leakhena Phoeung, et al.
The Medical Journal of Australia|March 3, 2021
Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infectionDavid R Darley, Gregory J Dore, Lucette Cysique, et al.
BMC Infectious Diseases|January 29, 2024
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS PilotNigel Carrington, Anna Conway, Jason Grebely, et al.
The Medical Journal of Australia|January 31, 2025
Decentralised COVID-19 molecular point-of-care testing: lessons from implementing a primary care-based network in remote Australian communitiesBelinda Hengel, Rebecca J Guy, Dawn Casey, et al.
The Lancet. Gastroenterology & Hepatology|April 27, 2017
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort studyJason Grebely, Francois M J Lamoury, Behzad Hajarizadeh, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Virological Methods|June 4, 2009
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesSally Land, Philip Cunningham, Jialun Zhou, et al.
The Journal of Molecular Diagnostics : JMD|July 1, 2018
Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot SamplesFrançois M J Lamoury, Behzad Hajarizadeh, Angelica Soker, et al.
Open Forum Infectious Diseases|November 29, 2023
Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot StudyAnna Conway, Annabelle Stevens, Carolyn Murray, et al.
Sexual Health|April 5, 2019
Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before-after studyPhillip Keen, Muhammad Jamil, Denton Callander, et al.
Journal of the International AIDS Society|July 22, 2024
Low HIV drug resistance prevalence among recently diagnosed HIV-positive men who have sex with men in a setting of high PrEP useJonathan M King, Francesca Di Giallonardo, Ansari Shaik, et al.
Diagnostic Microbiology and Infectious Disease|January 16, 2025
Establishing quality assurance for COVID-19 antigen tests in the Indo Pacific Region: A multi-site implementation studyJacqueline Prestedge, Marilyn Ninan, Chan Leakhena Phoeung, et al.
The Medical Journal of Australia|March 3, 2021
Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infectionDavid R Darley, Gregory J Dore, Lucette Cysique, et al.
BMC Infectious Diseases|January 29, 2024
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS PilotNigel Carrington, Anna Conway, Jason Grebely, et al.
The Medical Journal of Australia|January 31, 2025
Decentralised COVID-19 molecular point-of-care testing: lessons from implementing a primary care-based network in remote Australian communitiesBelinda Hengel, Rebecca J Guy, Dawn Casey, et al.
The Lancet. Gastroenterology & Hepatology|April 27, 2017
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort studyJason Grebely, Francois M J Lamoury, Behzad Hajarizadeh, et al.
Pageof 6